The role of self-efficacy in HIV treatment adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)

Journal of Behavioral Medicine

Volumn 30, Issue 5, 2007, Pages 359-370

  Johnson, Mallory O ^a   Neilands, Torsten B ^a   Dilworth, Samantha E ^a   Morin, Stephen F ^a   Remien, Robert H ^b   Chesney, Margaret A ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adherence; AIDS; HIV; Self efficacy

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; FEMALE; HEALTH CARE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PROBLEM SOLVING; RATING SCALE; RELIABILITY; SELF CARE; SELF CONCEPT; SOCIAL SUPPORT; STRESS; VALIDITY;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTI-RETROVIRAL AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR; SELF EFFICACY; SEXUAL BEHAVIOR;

EID: 34547642322     PISSN: 01607715     EISSN: 15733521     Source Type: Journal    
DOI: 10.1007/s10865-007-9118-3     Document Type: Article

References (58)

1. Amico, K. R., Harman, J. J., & Johnson, B. T. (2006). Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. Journal of Acquired Immune Deficiency Syndromes, 41(3), 285-297.
2. Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S123-S127.
3. Bandura, A. (1989). Human agency in social cognitive theory. American Psychologist, 44(9), 1175-1184.
4. Bandura, A., Valentine, E. R., Nesdale, A. R., Farr, R., Goodnow, J. J., Lloyd, B., et al. (1989). Social cognition. In J. P. Forgas & J. M. Innes (Eds.), Recent advances in social psychology: An international perspective. Amsterdam, Netherlands: North-Holland.
5. Bangsberg, D. R., Acosta, E. P., Gupta, R., Guzman, D., Riley, E. D., Harrigan, P. R., et al. (2006). Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. Aids, 20(2), 223-231.
6. Beck, A. T. (1967). Depression: Causes and treatment. Philadelphia, PA: University of Pennsylvania Press.
7. Beck, A. T., & Steer, R. A. (1984). Internal consistencies of the original and revised Beck Depression Inventory. Journal of Clinical Psychology, 40(6), 1365-1367.
8. Bentler, P. M., & Bonnett, D. G. (1980). Significance tests and goodness of fit in the analysis of covariance structures. Psychological Bulletin, 88, 588-606.
9. Browne, M. W., & Cudek, R. (1993). Alternative ways of assessing model fit. In K. A. Bollen & J. S. Long (Eds.), Testing structural equation models. Newbury Park, CA: Sage Publications.
10. Campbell, T. S., Lavoie, K. L., Bacon, S. L., Scharf, D., Aboussafy, D., & Ditto, B. (2006). Asthma self-efficacy, high frequency heart rate variability, and airflow obstruction during negative affect in daily life. International Journal of Psychophysiology, 62(1), 109-114.
11. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19(2), 124-133.
12. CDC. (2001). HIV/AIDS surveillance report: Midyear 2001 edition. MMWR CDC Surveillance Summaries, 13(1).
13. Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30 Suppl 2(3), S171-S176.
14. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255-266.
15. Chesney, M. A., Neilands, T. B., Chambers, D. B., Taylor, J. M., & Folkman, S. (2006). A validity and reliability study of the coping self-efficacy scale. British Journal of Health Psychology, 11(3), 421-437.
16. Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health & Social Behavior, 24(4), 385-396.
17. Cote, J. K., & Godin, G. (2005). Efficacy of interventions in improving adherence to antiretroviral therapy. International Journal of STD & AIDS, 16(5), 335-343.
18. Cunningham, W. E., Rana, H. M., Shapiro, M. F., & Hays, R. D. (1997). Reliability and validity of self-report CD4 counts-in persons hospitalized with HIV disease. The Journal of Clinical Epidemiology, 50(7), 829-835.
19. D'Zurilla, T. J., Nezu, A. M., & Maydeu-Olivares, A. (2002). Social problem solving inventory-revised. North Tonoawanda, NY: Multi-health Systems.
20. D'Zurilla, T. J., Nezu, A. M., & Maydeu-Olivares, A. (2004). Social problem solving: Theory and assessment. In E. Chang, T. J. D'Zurilla, & L. J. Sanna (Eds.), Social problem solving: Theory, research, and training (pp. 11-27). Washington, DC: American Psychological Association.
21. Devins, G. M., Armstrong, S. J., Mandin, H., & Paul, L. C. (1990). Recurrent pain, illness intrusiveness, and quality of life in end-stage renal disease. Pain, 42(3), 279-285.
22. Elliott, T. R., Johnson, M. O., & Jackson, R. (1997). Social problem solving and health behaviors of undergraduate students. Journal of College Student Development, 38(1), 24-31.
23. Fisher, J. D., Fisher, W. A., Amico, K. R., & Harman, J. J. (2006). An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychology, 25(4), 462-473.
24. Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports [Review]. Patient Education & Counseling, 46(2), 93-108.
25. Forsyth, A. D., & Carey, M. P. (1998). Measuring self-efficacy in the context of HIV risk reduction: research challenges and recommendations. Health Psychology, 17(6), 559-568.
26. Gard, G., Rivano, M., & Grahn, B. (2005). Development and reliability of the Motivation for Change Questionnaire. Disability and Rehabilitation, 27(17), 967-976.
27. Gerber, B. S., Pagcatipunan, M., Smith, E. V., Jr., Basu, S. S., Lawless, K. A., Smolin, L. I., et al. (2006). The assessment of diabetes knowledge and self-efficacy in a diverse population using Rasch measurement. Journal of Applied Measurement, 7(1), 55-73.
28. Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23(5), 386-395.
29. Gleeson-Kreig, J. M. (2006). Self-monitoring of physical activity: Effects on self-efficacy and behavior in people with type 2 diabetes. Diabetes Education, 32(1), 69-77.
30. Gore-Felton, C., Rotheram-Borus, M. J., Kelly, J. A., Weinhardt, L. S., Catz, S. L., Chesney, M. A., et al. (2005). Healthy Living Project: Individually-Tailored Multidimensional Intervention for HIV-Infected Persons. AIDS Education and Prevention, 17(SA), 21-39.
31. Gribble, J. N., Miller, H. G., Rogers, S. M., & Turner, C. F. (1999). Interview mode and measurement of sexual behaviors: Methodological issues. Journal of Sex Research, 36(1), 16-24.
32. Griffin, K. W., & Rabkin, J. G. (1997). Psychological distress in people with HIV/AIDS: Prevalence rates and methodological issues. AIDS & Behavior, 1(1), 29-42.
33. HLP (2007). Effects of a Behavioral Intervention to Reduce Risk of Transmission Among People Living With HIV: The Healthy Living Project Randomized Controlled Study. Journal of Acquired Immune Deficiency Syndromes, 44(2), 213-221.
34. Hu, L.-T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1-55.
35. Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E. D., et al. (2003). Theory guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the Healthy Living Project. AIDS Patient Care STDS, 17(12), 645-656.
36. Johnson, M. O., Elliott, T. R., Neilands, T. B., Morin, S. F., & Chesney, M. A. (2006). A Social Problem Solving Model of Adherence to HIV Medications. Health Psychology, 25(3), 355-363.
37. Kalichman, S. C., Cain, D., Fuhrel, A., Eaton, L., Di Fonzo, K., & Ertl, T. (2005). Assessing medication adherence self-efficacy among low-literacy patients: Development of a pictographic visual analogue scale. Health Education Research, 20(1), 24-35.
38. Kalichman, S. C., Rompa, D., & Cage, M. (2000). Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV/AIDS. International Journal of STD & AIDS, 11(9), 579-585.
39. Kalichman, S. C., Rompa, D., DiFonzo, K., Simpson, D., Austin, J., Luke, W., et al. (2001). HIV treatment adherence in women living with HIV/AIDS: research based on the Information-Motivation-Behavioral Skills model of health behavior. Journal of the Association of Nurses in AIDS Care, 12(4), 58-67.
40. McDonald, R. P. (1985). Factor analysis and related methods. Hillsdale, NJ: Lawrence Erlbaum and Associates.
41. Murphy, D. A., Greenwell, L., & Hoffman, D. (2002). Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health, 36(1), 97-111.
42. Ngamvitroj, A., & Kang, D. H. (in press). Effects of self-efficacy, social support and knowledge on adherence to PEFR self-monitoring among adults with asthma: A prospective repeated measures study. International Journal of Nursing Studies.
43. Ogedegbe, G., Mancuso, C. A., Allegrante, J. P., & Charlson, M. E. (2003). Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. The Journal of Clinical Epidemiology, 56(6), 520-529.
44. Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes, 36(5), 1100-1102.
45. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21-30.
46. Raykov, T. (1997). Estimation of composite reliability for congeneric measures. Applied Psychological Measurement, 21(2), 173-184.
47. Raykov, T., & Shrout, P. E. (2002). Reliability of scales with general structure: Point and interval estimation using a structural equation modeling approach. Structural Equation Modeling, 9, 195-212.
48. Reynolds, N. R., Testa, M. A., Marc, L. G., Chesney, M. A., Neidig, J. L., Smith, S. R., et al. (2004). Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study. Aids and Behavior, 8(2), 141-150.
49. Russell, D. W., & Cutrona, C. E. (1991). Social support, stress, and depressive symptoms among the elderly: Test of a process model. Psychology & Aging, 6(2), 190-201.
50. Sarkar, U., Fisher, L., & Schillinger, D. (2006). Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy?. Diabetes Care, 29(4), 823-829.
51. Simoni, J. M., Frick, P. A., Pantalone, D. W., & Turner, B. J. (2003). Antiretroviral adherence interventions: A review of current literature and ongoing studies. Topics in HIV Medicine, 11(6), 185-198.
52. Steenkamp, J.-B. E. M., & Baumgartner, H. (1998). Assessing measurement invariance in cross-national consumer research. Journal of Consumer Research, 25(1), 78-90.
53. Tonge, B., King, N., Klimkeit, E., Melvin, G., Heyne, D., & Gordon, M. (2005). The self-efficacy questionnaire for depression in adolescents (SEQ-DA). Development and psychometric evaluation. European Child & Adolescent Psychiatry, 14(7), 357-363.
54. Turner, C. F., Ku, L., Rogers, S. M., Lindberg, L. D., Pleck, J. H., & Sonenstein, F. L. (1998). Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science, 280(5365), 867-873.
55. Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. Aids, 16(2), 269-277.
56. Walsh, J. C., Pozniak, A. L., Nelson, M. R., Mandalia, S., & Gazzard, B. G. (2002). Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance. Journal of Acquired Immune Deficiency Syndromes, 30, 278-287.
57. Weinhardt, L. S., Kelly, J. A., Brondino, M. J., Rotheram-Borus, M. J., Kirshenbaum, S. B., Chesney, M. A., et al. (2004). HIV transmission risk behavior among men and women living with HIV in four U.S. cities. Journal of AIDS and Human Retrovirology, 36(5), 1057-1066.
58. Yuan, K.-H., & Bentler, P. M. (2000). Three likelihood-based methods for mean and covariance structure analysis with nonnormal missing data. In M. E. Sobel (Ed.), Sociological Methodology 2000 (pp. 165-200). Washington, DC: American Sociological Association.